The “Next Bitcoin”? 10 CENT Crypto Set to Explode

The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…

Thomas Secor Biography and Net Worth

Director of Novanta

Mr. Secor has been Managing Director of Morningside Heights Capital, an investment firm, since March 2012. From April 2007 until March 2012, Mr. Secor was employed by Goldman Sachs & Co [NYSE: GS], where he worked with Liberty Harbor, an absolute-return investment fund. While at Liberty Harbor, Mr. Secor focused on the fund’s fundamental investment strategies, including debt and equity transactions. From 2005 until March 2007, Mr. Secor was a Director and member of the legal group at Amaranth Advisors, an investment advisor. From 1998 until 2005, Mr. Secor was an attorney with Cleary, Gottlieb, Steen & Hamilton where he specialized in corporate and securities law. Mr. Secor previously served on the boards of directors of The Great Atlantic and Pacific Tea Company (A&P) and Wolverine Advanced Materials, both privately held companies. Mr. Secor received his B.A., cum laude, from Pomona College and his J.D., cum laude, from the University of Chicago Law School. Mr. Secor brings to the Company’s Board of Directors more than 20 years of experience in strategic transactions, corporate finance and profit management across a wide range of industries, as well as extensive corporate governance experience.

What is Thomas N. Secor's net worth?: The estimated net worth of Thomas N. Secor is at least $176,148.05 as of October 28th, 2022. Mr. Secor owns 1,105 shares of Novanta stock worth more than $176,148 as of April 27th. This net worth approximation does not reflect any other assets that Mr. Secor may own. Learn More about Thomas N. Secor's net worth.
How do I contact Thomas N. Secor?: The corporate mailing address for Mr. Secor and other Novanta executives is 125 Middlesex Turnpike, Bedford MA, 01730. Novanta can also be reached via phone at (781) 266-5700 and via email at [email protected]. Learn More on Thomas N. Secor's contact information.
Has Thomas N. Secor been buying or selling shares of Novanta?: Thomas N. Secor has not been actively trading shares of Novanta during the last quarter. Most recently, Thomas N. Secor sold 550 shares of the business's stock in a transaction on Friday, October 28th. The shares were sold at an average price of $140.00, for a transaction totalling $77,000.00. Following the completion of the sale, the director now directly owns 1,105 shares of the company's stock, valued at $154,700. Learn More on Thomas N. Secor's trading history.
Who are Novanta's active insiders?: Novanta's insider roster includes Robert Buckley (CFO), Peter Chang (CAO), Matthijs Glastra (CEO), Thomas Secor (Director), and Brian Young (Insider). Learn More on Novanta's active insiders.
Are insiders buying or selling shares of Novanta?: In the last twelve months, insiders at the technology company sold shares 10 times. They sold a total of 27,400 shares worth more than $4,471,657.00. The most recent insider tranaction occured on April, 1st when CEO Matthijs Glastra sold 5,000 shares worth more than $860,000.00. Insiders at Novanta own 1.2% of the company. Learn More about insider trades at Novanta.
Information on this page was last updated on 4/1/2024.

Thomas N. Secor Insider Trading History at Novanta

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/28/2022	Sell	550	$140.00	$77,000.00	1,105
10/24/2022	Sell	550	$125.00	$68,750.00	1,655

Thomas N. Secor Buying and Selling Activity at Novanta

Novanta Company Overview

Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. The Robotics and Automation segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.

Today's Range

Now: $159.41

$156.37

$160.29

50 Day Range

MA: $166.87

$149.41

$178.38

2 Week Range

Now: $159.41

$111.20

$187.60

Volume

118,492 shs

Average Volume

130,868 shs

Market Capitalization

$5.71 billion

P/E Ratio

78.53

Dividend Yield

N/A

Beta

1.33

The “Next Bitcoin”? 10 CENT Crypto Set to Explode

From True Market Insiders | Ad